Neurizon Email Formats

Biotechnology Research • 385 Bourke Street, Suite 2, Australia • 11-20 Employees

Neurizon Email Formats

Neurizon uses 2 email formats. The most common is {first initial} (e.g., j@neurizon.com), used 61.5% of the time.

Format	Example	Percentage
{first initial}	j@neurizon.com	61.5%
{first name}	john@neurizon.com	38.5%

Key Contacts at Neurizon

Michael Thurn

Managing Director And Chief Executive Officer

Katie Macfarlane

Member Board Of Directors

Marcus Hughes

Non Executive Director

Company overview

Headquarters	385 Bourke Street, Suite 2, Level 11, Melbourne, Victoria 3000, AU
Phone number	+61396927222
Website	neurizon.com
NAICS	541714
Keywords	Biotechnology, Pharmaceutical, Neurodegenerative Diseases, Drug Manufacturing, Amyotrophic Lateral Sclerosis, Motor Neurone Disease
Employees	11-20
Socials

About Neurizon

Neurizon Therapeutics Limited (ASX: NUZ), formerly known as PharmAust, is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications. Through international collaborations and rigorous clinical programs, Neurizon is dedicated to creating new horizons for patients and families impacted by complex neural disorders.